Pharis Mohideen serves as Executive at Millendo Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Pharis Mohideen has executed 15 insider transactions totaling $38.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 21, 2025 involved receiving (via award) 44,000 shares valued at $0.
Pharis Mohideen currently holds 145,529 shares of Millendo Therapeutics, Inc. (MLND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pharis Mohideen has been a net seller of MLND stock. They have purchased $0 and sold $38.1K worth of shares.
Pharis Mohideen's most recent insider trade was on Nov 21, 2025, when they sold 44,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $2.77 |
| Discretionary |
| Nov 20, 2025 | DBVT | $18.7K | Sale | 6,496 | $2.88 | Discretionary |
| Jul 29, 2025 | DBVT | $1.0K | Sale | 464 | $2.22 | Discretionary |
| Jul 29, 2024 | DBVT | $1.7K | Sale | 1,785 | $0.98 | Discretionary |
| May 24, 2024 | DBVT | $898 | Sale | 660 | $1.36 | Discretionary |
| May 22, 2024 | DBVT | $527 | Sale | 382 | $1.38 | Discretionary |
| Nov 22, 2023 | DBVT | $3.9K | Sale | 2,245 | $1.74 | Discretionary |
| Nov 20, 2023 | DBVT | $0 | Award | 35,000 | $N/A | Discretionary |
| May 24, 2023 | DBVT | $1.7K | Sale | 469 | $3.54 | Discretionary |
| Nov 24, 2022 | DBVT | $5.2K | Sale | 1,792 | $2.88 | Discretionary |
| Nov 21, 2022 | DBVT | $0 | Award | 17,500 | $N/A | Discretionary |
| Jul 29, 2022 | DBVT | $0 | Award | 10,000 | $N/A | Discretionary |
| Nov 22, 2021 | DBVT | $0 | Award | 8,700 | $N/A | Discretionary |
| Dec 7, 2018 | MLND | $0 | Award | 7,440 | $N/A | Discretionary |